Panacea Index Logo

Command Palette

Search for a command to run...

Prevention of falls and fractures in old people by administration of calcium and vitamin D, randomized clinical trial.

BMC public health
January 1, 1970
Jesús López-Torres Hidalgo
Clinical Trial, Phase IIIComparative StudyJournal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine whether calcium and vitamin D supplementation improves musculoskeletal function and reduces falls in individuals aged over 65 years.

Results Summary

The study is designed to evaluate the efficacy of calcium and vitamin D supplementation in reducing falls and fractures, but the abstract does not provide specific results. The primary outcome is the incidence of spontaneous falls, with secondary outcomes including fractures, hospitalization needs, and changes in bone mass and muscle strength.

Population

Non-institutionalized individuals aged 65 years or older.

Effective Dosage

1000 mg of calcium and 800 IU of vitamin D daily.

Duration

Two years.

Interactions

None mentioned.

Extracted Claims (5)
InterventionDirectionEndpointPopulationDosageImpactClaim #
calcium and vitamin D supplementation
increase
musculoskeletal function
person aged over 65 years
-
determine the effectiveness in improving
#1
calcium and vitamin D supplementation
decrease
number of falls
person aged over 65 years
-
determine the effectiveness in decreasing
#2
test drug containing 800 IU of vitamin D and 1000 mg of calcium
neutral
-
704 non-institutionalized subjects aged 65 years or older
-
administered daily
#3
calcium and vitamin D supplementation
decrease
falls
elderly population
-
effective in the prevention of
#4
calcium and vitamin D supplementation
decrease
fractures
elderly population
-
effective in the prevention of
#5
Abstract

BACKGROUND: There are many studies that associate vitamin D serum levels in older persons with muscle strength, physical performance and risk of fractures and falls. However, current evidence is insufficient to make a general recommendation for administrating calcium and vitamin D to older persons. The objective of this study is to determine the effectiveness of calcium and vitamin D supplementation in improving musculoskeletal function and decreasing the number of falls in person aged over 65 years. METHODS/DESIGN: Phase III, randomized, double blind, placebo-controlled trial to evaluate the efficacy of already marketed drugs in a new indication. It will be performed at Primary Care doctor visits at several Healthcare Centers in different Spanish Health Areas. A total of 704 non-institutionalized subjects aged 65 years or older will be studied (sample size calculated for a statistical power of 80%, alpha error 0.05, annual incidence of falls 30% and expected reduction of 30% to 20% and expected loss to follow up of 20%). The test drug containing 800 IU of vitamin D and 1000 mg of calcium will be administered daily. The control group will receive a placebo. The subjects will be followed up over two years. The primary variable will be the incidence of spontaneous falls. The secondary variables will include: consequences of the falls (fractures, need for hospitalization), change in calcidiol plasma levels and other analytical determinations (transaminases, PTH, calcium/phosphorous, albumin, creatinine, etc.), change in bone mass by densitometry, change in muscle strength in the dominant hand and change in musculoskeletal strength, risk factors for falls, treatment compliance, adverse effects and socio-demographic data. DISCUSSION: The following principles have been considered in the development of this Project: the product data are sufficient to ensure that the risks assumed by the study participants are acceptable, the study objectives will probably provide further knowledge on the problem studied and the available information justifies the performance of the study and its possible risk for the participants.If calcium and vitamin D supplementation is effective in the prevention of falls and fractures in the elderly population, a recommendation may be issued with the aim of preventing some of the consequences of falls that affect quality of life and the ensuing personal, health and social costs. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01452243

Medical Subject Headings (MeSH)
Accidental FallsAgedBone Density Conservation AgentsCalciumDietary SupplementsDouble-Blind MethodDrug Administration ScheduleFemaleFollow-Up StudiesFractures, BoneHumansMaleMuscle StrengthOffice VisitsPatient CompliancePrimary Health CareQuality of LifeRecovery of FunctionRiskSpainSurvival AnalysisTreatment OutcomeVitamin DVitamin D Deficiency
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality85/10
Citation Metrics
Total Citations7
Citations/Year0.5
Relative Citation Ratio0.30
NIH Percentile15.7%
Research Impact Scores
APT Score0.50
Weight Score1.67
Normalized Score0.67
Related Supplements